Interleukin-2 (intratumoral)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Interleukin-2 (intratumoral), covering 2015-07-21 to 2015-07-21. Get the full timeline:
Most recent: Clinical Trial Update: A Phase II Study to Evaluate Safety and Efficacy of Combined Treatment With Ipilimumab and Intratumoral Interleukin-2 [Phase 2]